Unlock instant, AI-driven research and patent intelligence for your innovation.
A traditional Chinese medicine for treating thrombocytopenic purpura
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of platelets and traditional Chinese medicine, which is applied in the direction of blood diseases, drug combinations, and medical formulas, can solve the problems of short curative effect, damage, and high price of gamma globulin, and achieve the effects of low toxic and side effects, significant curative effect, and good application prospects
Active Publication Date: 2016-06-22
袁军清
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Hormone drugs can cause certain damage to human bone marrow, gamma globulin is expensive, and its effect and curative effect are short
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] A traditional Chinese medicine for treating thrombocytopenic purpura, comprising the following components by weight: 160g of dogwood, 120g of sheep's trotter, 100g of notoginseng, 120g of astragalus, 120g of angelica, 120g of medlar, 100g of privet fruit, 100g of Eclipta chinensis, and Caulis Spatholobus 100g, American ginseng 20g, purple pearl 80g. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
Embodiment 2
[0023] A traditional Chinese medicine for treating thrombocytopenic purpura, comprising the following components by weight: 150g of dogwood, 130g of sheep's trotter, 90g of notoginseng, 130g of astragalus, 110g of angelica, 130g of medlar, 90g of privet fruit, 110g of Eclipta chinensis, and Caulis Spatholobus 90g, 22g American ginseng, 78g purple pearl, 15g jujube, 6g madder, 9g Puhuang. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
Embodiment 3
[0025] A traditional Chinese medicine for treating thrombocytopenic purpura, comprising the following components by weight: 170g of dogwood, 110g of sheep's trotter, 110g of notoginseng, 110g of astragalus, 130g of angelica, 110g of medlar, 110g of privet fruit, 90g of Eclipta chinensis, and Caulis Spatholobus 110g, 18g American ginseng, 82g purple pearl, 6g jujube, 9g madder, 5g cattail. After washing, drying, pulverizing, sieving and mixing the components, purified water is added to make water pills. The mass ratio of the mixed medicinal powder to purified water is 1:0.3, and the pellets are dried to a water content of 5%.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a traditional Chinese medicine for treating thrombocytopenic purpura. The traditional Chinese medicine comprises the following components in parts by weight: 150 to 170g of cornus officinalis, 110 to 130g of rumex japonicas, 90 to 110g of pseudo-ginseng, 110 to 130g of astragalus membranaceus, 110 to 130g of angelica sinensis, 110 to 130g of fructus lycii, 90 to 110g of glossy privet fruit, 90 to 110g of herba ecliptae, 90 to 110g of caulis spatholobi, 18 to 22g of american ginseng, and 78 to 82g of callicarpa bodinieri. Other components in parts by weight also can be added to the traditional Chinese medicine based on the components as follows: 6 to 15g of fructus ziziphi jujubae, 6 to 9g of rubia cordifolia and 5 to 9g of cattail pollen. Under the coordination of all the components, the traditional Chinese medicine has the effects of clearing heat and cooling blood, replenishing blood and tonifying Qi, dispersing blood stasis and stopping bleeding and treating the deficiency of both blood and Qi and stagnation of heat stasis leading to thrombocytopenic purpura, such as skin petechiae, ecchymosis, black red, thrombocytopenia, hemorrhage, fever, polydipsia, palpitation, insomnia, vertigo, lack of energy, pain in joints, waist and abdomen, dark urine with burning sensation and constipation. The result of clinical application shows that the traditional Chinese medicine is remarkable in therapeutic effect and low in toxic and side effects and has a good application prospect.
Description
technical field [0001] The invention relates to a traditional Chinese medicine for treating thrombocytopenic purpura. Background technique [0002] Thrombocytopenic purpura is a common clinical bleeding disorder characterized by spontaneous bleeding, thrombocytopenia, prolonged bleeding time and poor clot contraction. The development and maturation of megakaryocytes in BM is inhibited. Recent research results show that the pathogenesis of the disease is related to immunity. In cases of thrombocytopenia without a specific etiology, about 85% of patients have IgG antibodies in serum or platelets. [0003] The characteristics of thrombocytopenic purpura: the lifespan of platelets is obviously shortened, anti-platelet autoantibodies appear, bone marrow megakaryocytes increase, maturation disorder, and platelet renewal accelerate. Clinically, it can be divided into two types: acute and chronic. The former is usually self-limiting, mostly in children, while the latter is more com...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.